Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa C Iacono

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumorsLars M Wagner, Kristine R Crews, Lisa C Iacono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumorClinton F Stewart, Lisa C Iacono, Murali Chintagumpala, et al.
Journal of Neuro-Oncology|October 4, 2005
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in childrenAlberto Broniscer, Murali Chintagumpala, Maryam Fouladi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group StudyNajat C Daw, Wayne L Furman, Clinton F Stewart, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumorsLars M Wagner, Kristine R Crews, Lisa C Iacono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumorClinton F Stewart, Lisa C Iacono, Murali Chintagumpala, et al.
Journal of Neuro-Oncology|October 4, 2005
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in childrenAlberto Broniscer, Murali Chintagumpala, Maryam Fouladi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group StudyNajat C Daw, Wayne L Furman, Clinton F Stewart, et al.
Pageof 2